SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

Jan 4 2023
BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Jan. 4, 2023-- SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Legal Contracts Specialist United States Legal & Compliance
Technical Accounting & Reporting Manager Switzerland. United States Finance
Senior Lab Technician - NGS Switzerland Data Science
Bioinformatics Engineer (12 Month Contract) Switzerland Data Science
Distribution & Logistics Associate Switzerland Operations